Edwards reported third-quarter results with constant-currency revenue growth of 11%, while adjusted operating margin rose 280 basis points as spending on research and development and sales and marketing eased from the prior-year period.
Edwards' efforts to focus on efficiency and higher-margin products have paid off, as gross margins increased from 47% in 2000 to 78% in 2025.
Edwards' ambitions to diversify into minimally invasive medical technologies place the firm in direct competition with much larger competitors, such as Medtronic and Abbott, which can easily bid up prices for emerging technologies that Edwards couldn't match.
Metric | EW | ABT | MDT |
|---|---|---|---|
Price/Earnings (Normalized) | 40.68 | 20.53 | 17.95 |
Price/Book Value | 5.51 | 3.75 | 2.59 |
Price/Sales | 9.03 | 3.99 | 3.48 |
Price/Cash Flow | 33.52 | 18.48 | 14.58 |
Metric | EW | ABT | MDT |
|---|---|---|---|
Quick Ratio | 3.54 | 1.00 | 1.29 |
Current Ratio | 4.60 | 1.45 | 2.07 |
Interest Coverage | — | 7.30 | 10.12 |
Metric | EW | ABT | MDT |
|---|---|---|---|
Return on Assets (Normalized) | 12.45% | 9.44% | 8.31% |
Return on Equity (Normalized) | 16.24% | 18.30% | 15.59% |
Return on Invested Capital (Normalized) | 14.33% | 12.90% | 10.57% |
1-Day Chart | Name | Price | Morningstar Rating for Stocks | Capital Allocation | Economic Moat | Market Cap |
|---|---|---|---|---|---|---|
| Abbott Laboratories ABT | LOCK|^@%yskr | LOCK|g@>nB | $191B | |||
| Medtronic PLC MDT | LOCK|cNV@>j | LOCK|zcTx | $130B | |||
| Stryker Corp SYK | LOCK|y#?V@lBL | LOCK|g# | $123B | |||
| Boston Scientific Corp BSX | LOCK|#xHH<T | LOCK|@nk!$ | $65B | |||
| GE HealthCare Technologies Inc Common Stock GEHC | LOCK|x^yb^$c | LOCK|!GK | $38B | |||
| DexCom Inc DXCM | LOCK|FCbwQW%C | LOCK|yd## | $30B | |||
| Koninklijke Philips NV ADR PHG | LOCK|^$q | LOCK|<%# | $30B | |||
| Steris PLC STE | LOCK|!r@S!t | LOCK|j%#x | $25B | |||
| Zimmer Biomet Holdings Inc ZBH | LOCK|R<dSPcKc | LOCK|$>% | $20B |
United States